GL1X · GenesisL1 explorer

MolNFT v1 · #118455 · protein

Expanding NATURE'S catalytic repertoire -directed evolution of an artificial metalloenzyme for in vivo metathesis

5F2B · Streptavidin: “Expanding NATURE'S catalytic repertoire -directed evolution of an artificial metalloenzyme for in vivo…”. X-ray diffraction, 2 ligands (9RU, SO4), 1 pocket (best druggability 0.48). MolNFT v1 #118455 on GenesisL1: 3D…

PDB
5F2B
Type
protein
Length
122 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Streptavidin
UniProt
P22629
Ligands
9RU, SO4
Pockets
1 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStreptavidinprotein1228% helix, 55% strandP22629

Ligands and binding sites

  • 9RU · [1-[4-[[5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]methyl]-2,6-dimethyl-phenyl]-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-1-ium-2-yl]-bis(chloranyl)ruthenium · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11080.480.80199RU

Compared structures

  • 5F2B · Expanding Nature's Catalytic Repertoire -Directed Evolution of an Artificial… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.